CENTOGENE N.V. (CNTG) - Company Sales

Geopolitical barriers and data laws complicate the global collection of biomaterials. Centogene N.V. (CNTG) gross sales volume dynamics demonstrate resilience, with this metric equaling 0.00. Business efficiency relies on external express sample logistics, while the strategy focuses on profit optimization and the diagnosis of rare pathologies for pharmaceutical partners.

CNTG CENTOGENE: Company Revenue in the range 07/04/2022 - 08/17/2024

Analytical breakdowns for Centogene N.V.

- market value and analyst target forecast:

Market Chart centogene.com|CNTG - Analyst Consensus Forecast

- market capitalization indicators:

Market Valuation CENTOGENE N.V.|CNTG - Enterprise Value

- balance sheet equity data:

Net Asset Value per Share CENTOGENE|CNTG - Company Book Value|Capitalization to Book Value Ratio centogene.com|CNTG - Cumulative Company Assets

- debt and solvency information:

- business earnings and investment ratios data:

CNTG - Net Profit|Expected Net Profit Centogene N.V.|CNTG - Price to Earnings Ratio|Future Price to Earnings Multiple Centogene N.V.|CNTG - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation CENTOGENE N.V.|CNTG - Operating profit before deduction of amortization|Net earnings per share for the last four quarters CENTOGENE|CNTG - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months centogene.com|CNTG - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year Centogene N.V.

- sales volume and revenue indicators:

CNTG - Revenue and Sales Volume|Company Future Sales Volume CENTOGENE N.V.|CNTG - Price-to-Revenue Ratio|Market Cap to Projected Revenue CENTOGENE N.V.

Summary company analysis:CNTG - Centogene

Daily sales measure daily cash flow, allowing investors to assess business scaling rates and revenue resilience to market shocks. By analyzing the sales metrics of Centogene N.V. (CNTG), one can track the efficiency of international biosample logistics, where delivery speed converts directly into operating income, making this indicator a key marker of medical supply chain reliability.

Key competitors